Physician profile
Joy Wang
NPI 1740785971
$5,521.48
in general payments reported to CMS, 2019-2025
11 companies · $856 in 2025
The $856 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $23.48 · 2021: $248 · 2022: $161 · 2023: $1,525 · 2024: $2,325 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,200 · Consulting Fee: $1,600 · Food and Beverage: $524 · Travel and Lodging: $293 · Education: $88.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,200.00 |
| Consulting Fee | $1,600.00 |
| Food and Beverage | $523.77 |
| Travel and Lodging | $292.96 |
| Education | $88.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eko Health, INC. | $3,800.00 | 2023-2024 | |
| Inspire Medical Systems, INC. | $499.36 | 2023-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $340.20 | 2025 | Opsumit, Uptravi |
| Pfizer INC. | $301.74 | 2019-2021 | |
| Abbvie INC. | $131.61 | 2021 | |
| Allergan, INC. | $120.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $101.45 | 2021 | |
| Amgen INC. | $82.38 | 2022 | |
| United Therapeutics Corporation | $78.58 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.09 | 2025 | Ofev |
| Ethicon INC. | $25.07 | 2025 | Monarch Platform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.